Learn More
Medchemexpress LLC N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide | 345627-80-7 | MFCD09833875 | 99.9% | 380.53 g/mol | C17H24N4O2S2 | 50 MG

Supplier: Medchemexpress LLC HY1000850MG
SNS-032 is a small-molecule research compound that selectively inhibits cyclin-dependent kinases CDK2, CDK7, and CDK9 (IC50s: 38 nM, 62 nM, 4 nM, respectively). It is used in preclinical studies to probe cell-cycle regulation, transcriptional control, apoptosis induction, and angiogenesis inhibition.
- Selective inhibition of CDK2, CDK7, and CDK9.
- Potent transcriptional inhibitor reducing RNA polymerase II phosphorylation.
- Demonstrated antitumor activity in preclinical cell models.
- Reversible activity suitable for washout and time-course studies.
- Available in small package sizes for laboratory research use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.